Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The continuum home program concept.

Clinical nephrology·2008
Same author

Definition of recurrent peritonitis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2007
Same author

Peritoneal dialysis solutions--at a crossroad.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2006
Same author

Complications of peritoneal dialysis catheters: early and late.

The International journal of artificial organs·2006
Same author

Continuous flow peritoneal dialysis.

Nephrology news & issues·2002
Same author

Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2002

Related Experiment Video

Updated: Jul 8, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Prescription writing: CAPD and PD plus.

J A Diaz-Buxo1

  • 1Fresenius Medical Care North America, Waltham, MA, USA. jose.diaz-buxo@fmc-na.com

Clinical Nephrology
|January 11, 2008
PubMed
Summary

Optimizing prescriptions for automated peritoneal dialysis (APD) improves patient outcomes. Careful adjustments can minimize sodium loss and enhance dialysis effectiveness when standard CAPD is insufficient.

Area of Science:

  • Nephrology
  • Renal Replacement Therapy
  • Dialysis Technology

Background:

  • Continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) are key treatments for kidney failure.
  • Prescription formulation relies on equilibration dialysis principles.
  • Understanding patient transport is crucial for effective dialysis.

Purpose of the Study:

  • To evaluate the correlation between predicted and observed clearances and ultrafiltration in CAPD and APD.
  • To identify strategies for optimizing APD prescriptions.
  • To determine when PD plus is indicated over CAPD.

Main Methods:

  • Analysis of prescription formulations for CAPD and PD plus.
  • Comparison of predicted versus clinically observed clearances and ultrafiltration.

Related Experiment Videos

Last Updated: Jul 8, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

  • Investigation of the impact of dialysate flows and sodium sieving in APD.
  • Main Results:

    • Good correlation exists between predicted and observed clearances and ultrafiltration, especially in average transporters.
    • Higher dialysate flows in APD can reduce sodium removal due to sodium sieving.
    • Optimal APD prescriptions can minimize sodium sieving.

    Conclusions:

    • APD prescriptions can be optimized to improve efficacy and minimize side effects like sodium loss.
    • PD plus is a viable option when CAPD cannot meet dialysis adequacy targets.